WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A12 MINERAL SUPPLEMENTS

This group contains mineral supplements used for treatment of mineral deficiency. Magnesium carbonate used for treatment of mineral deficiency is classified in A02AA01.


A12C OTHER MINERAL SUPPLEMENTS

This group comprises other minerals.

See also B05 - Blood substitutes and perfusion solutions.


A12CA Sodium

The DDD has been set to 1 g NaCl.

A12CB Zinc

The DDD is based on treatment of zinc deficiency.

A12CC Magnesium

The DDDs for the various magnesium salts are equivalent to an assumed daily requirement of 300 mg Mg (oral dose). The DDD for some of the oral formulations are higher than the parenteral formulations due to lower bioavailability.

A12CD Fluoride

This group comprises preparations used e.g. in the treatment of osteoporosis. Fluoride used in caries prophylaxis, see A01AA - Caries prophylatic agents.

Bisphosphonates are classified in M05B.
Calcitonin is classified in H05BA.
Calcium preparations are classified in A12A.
Combinations with calcium are classified here.

The DDD is based on treatment of osteoporosis.

A12CE Selenium

The DDDs are based on treatment of selenium deficiency and is expressed as amount of selenium (Se).

A12CX Other mineral products

Last updated: 2013-12-19